Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | ---- | ---- | 29.35%2.4B | ---- | ---- | ---- | 1,683.27%1.85B | ---- | ---- |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | ---- | ---- | -11.36%-194.62M | ---- | ---- | ---- | -201.48%-174.78M | ---- | ---- |
| Dividend (income)- adjustment | ---- | ---- | ---- | 3.32%-7.11M | ---- | ---- | ---- | -66.18%-7.36M | ---- | ---- |
| Investment loss (gain) | ---- | ---- | ---- | 45.67%-55.16M | ---- | ---- | ---- | -18.88%-101.52M | ---- | ---- |
| Attributable subsidiary (profit) loss | ---- | ---- | ---- | -131.73%-10.6M | ---- | ---- | ---- | 136.46%33.4M | ---- | ---- |
| Impairment and provisions: | ---- | ---- | ---- | -202.03%-17.79M | ---- | ---- | ---- | -38.52%17.44M | ---- | ---- |
| -Impairmen of inventory (reversal) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---45K | ---- | ---- |
| -Other impairments and provisions | ---- | ---- | ---- | -201.77%-17.79M | ---- | ---- | ---- | -38.36%17.48M | ---- | ---- |
| Revaluation surplus: | ---- | ---- | ---- | -183.10%-27M | ---- | ---- | ---- | 131.72%32.49M | ---- | ---- |
| -Other fair value changes | ---- | ---- | ---- | -183.10%-27M | ---- | ---- | ---- | 131.72%32.49M | ---- | ---- |
| Asset sale loss (gain): | ---- | ---- | ---- | -105.36%-139K | ---- | ---- | ---- | 2,913.95%2.59M | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | -105.36%-139K | ---- | ---- | ---- | 2,913.95%2.59M | ---- | ---- |
| Depreciation and amortization: | ---- | ---- | ---- | 18.87%1.08B | ---- | ---- | ---- | 8.40%910.76M | ---- | ---- |
| -Amortization of intangible assets | ---- | ---- | ---- | 7.10%726.79M | ---- | ---- | ---- | 6.07%678.62M | ---- | ---- |
| Financial expense | ---- | ---- | ---- | 47.02%230.9M | ---- | ---- | ---- | 14.86%157.05M | ---- | ---- |
| Exchange Loss (gain) | ---- | ---- | ---- | 43.98%96.13M | ---- | ---- | ---- | -69.00%66.77M | ---- | ---- |
| Special items | ---- | ---- | ---- | 29.65%417.2M | ---- | ---- | ---- | -25.40%321.79M | ---- | ---- |
| Operating profit before the change of operating capital | ---- | ---- | ---- | 25.70%3.91B | ---- | ---- | ---- | 139.61%3.11B | ---- | ---- |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | ---- | ---- | -404.36%-4.95M | ---- | ---- | ---- | --1.63M | ---- | ---- |
| Accounts receivable (increase)decrease | ---- | ---- | ---- | -909.09%-477.22M | ---- | ---- | ---- | 75.19%-47.29M | ---- | ---- |
| Accounts payable increase (decrease) | ---- | ---- | ---- | -72.51%646.93M | ---- | ---- | ---- | 276.51%2.35B | ---- | ---- |
| prepayments (increase)decrease | ---- | ---- | ---- | 36.31%-865.73M | ---- | ---- | ---- | 5.28%-1.36B | ---- | ---- |
| Special items for working capital changes | ---- | ---- | ---- | 133.94%12.91M | ---- | ---- | ---- | ---38.03M | ---- | ---- |
| Cash from business operations | ---- | 136.58%3.26B | ---- | -19.85%3.22B | ---- | -38.92%1.38B | ---- | 1,248.29%4.02B | ---- | 1,007.87%2.26B |
| Other taxs | ---- | -70.99%-307.75M | ---- | -126.04%-435.05M | ---- | -238.13%-179.99M | ---- | -285.22%-192.47M | ---- | -65.06%-53.23M |
| Interest received - operating | ---- | -14.48%82.61M | ---- | 4.46%180.76M | ---- | 41.38%96.6M | ---- | 220.97%173.04M | ---- | 313.67%68.33M |
| Special items of business | 419.02%3.36B | ---- | -22.95%373.28M | ---- | -78.27%647.06M | ---- | -44.58%484.47M | ---- | 394.40%2.98B | ---- |
| Net cash from operations | 419.02%3.36B | 134.43%3.04B | -22.95%373.28M | -25.82%2.97B | -78.27%647.06M | -43.00%1.29B | -44.58%484.47M | 1,224.26%4B | 394.40%2.98B | 1,108.64%2.27B |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | --4.46M | ---- | ---- | ---- | ---- | ---- | 154.45%1M | ---- | ---- |
| Dividend received - investment | ---- | 21.19%52.38M | ---- | 243.33%53.81M | ---- | 272.34%43.22M | ---- | -43.51%15.67M | ---- | --11.61M |
| Restricted cash (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -615.76%-10.94M |
| Loan receivable (increase) decrease | ---- | -576.69%-171.42M | ---- | 8.32%-73.59M | ---- | -153.32%-25.33M | ---- | -399.02%-80.26M | ---- | -355.36%-10M |
| Sale of fixed assets | ---- | -89.77%1.38M | ---- | 380.96%18.47M | ---- | 1,306.96%13.54M | ---- | 2,947.62%3.84M | ---- | -69.63%962K |
| Purchase of fixed assets | ---- | 39.81%-224.32M | ---- | 47.76%-403.16M | ---- | -170.52%-372.68M | ---- | -49.75%-771.68M | ---- | -36.77%-137.77M |
| Purchase of intangible assets | ---- | -383.43%-31.94M | ---- | 93.99%-12.17M | ---- | -719.73%-6.61M | ---- | -1,043.49%-202.49M | ---- | 95.22%-806K |
| Sale of subsidiaries | ---- | 105.66%669K | ---- | ---12.19M | ---- | ---11.83M | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | 86.67%-30.89M | ---- | ---- | ---- | -22.04%-231.71M | ---- | ---- | ---- | -596.15%-189.87M |
| Recovery of cash from investments | ---- | 1.61%4.35B | ---- | 88.03%7.93B | ---- | 170.68%4.28B | ---- | -58.07%4.22B | ---- | -68.57%1.58B |
| Cash on investment | ---- | -140.67%-7.52B | ---- | -108.50%-7.72B | ---- | -131.22%-3.12B | ---- | 61.33%-3.7B | ---- | 78.33%-1.35B |
| Other items in the investment business | -1,218.31%-4.59B | -32.18%5.85M | -190.27%-1.12B | 50.45%-616.28M | 51.03%-348.23M | 297.97%8.62M | 747.18%1.24B | -266.03%-1.24B | -122.83%-711.15M | --2.17M |
| Net cash from investment operations | -1,218.31%-4.59B | -717.17%-3.56B | -190.27%-1.12B | 52.66%-834.26M | 51.03%-348.23M | 658.64%576.75M | 747.18%1.24B | -343.85%-1.76B | -122.83%-711.15M | 92.28%-103.24M |
| Net cash before financing | -512.39%-1.23B | -128.02%-524.38M | -143.14%-742.09M | -4.71%2.14B | -86.82%298.83M | -13.68%1.87B | 151.75%1.72B | 2,466.26%2.24B | 270.34%2.27B | 288.58%2.17B |
| Cash flow from financing activities | ||||||||||
| New borrowing | ---- | -78.93%598.42M | ---- | 247.25%2.5B | ---- | 1,319.94%2.84B | ---- | -63.88%720M | ---- | -89.44%200M |
| Refund | ---- | 67.47%-768.47M | ---- | -36.87%-1.08B | ---- | -362.98%-2.36B | ---- | -1,046.99%-792.65M | ---- | -2,340.64%-510.24M |
| Issuing shares | ---- | -42.16%146.2M | ---- | 402.89%285.23M | ---- | 768.50%252.78M | ---- | -43.49%56.72M | ---- | 117.71%29.11M |
| Dividends paid - financing | ---- | 95.01%-215K | ---- | -15,423.10%-316.52M | ---- | ---4.31M | ---- | ---2.04M | ---- | ---- |
| Absorb investment income | ---- | -99.97%2K | ---- | -47.87%11.72M | ---- | 419.73%7.8M | ---- | 59.56%22.48M | ---- | -66.67%1.5M |
| Other items of the financing business | -431.98%-970.82M | -479.19%-1.14M | -134.68%-301.98M | -11.51%-595.9M | 154.74%292.43M | 96.73%-197K | 351.11%870.71M | -13.36%-534.38M | -128.61%-534.22M | 53.50%-6.03M |
| Net cash from financing operations | -431.98%-970.82M | -131.52%-216.86M | -134.68%-301.98M | 214.62%678.8M | 154.74%292.43M | 316.48%688.03M | 351.11%870.71M | -138.57%-592.23M | -128.61%-534.22M | -117.12%-317.83M |
| Effect of rate | 34.78%-30.25M | -59.75%-6.24M | -207.26%-7.4M | 466.53%13.15M | -2,046.33%-46.38M | -151.67%-3.91M | 59.58%-2.41M | -105.92%-3.59M | -96.82%2.38M | -87.64%7.56M |
| Net Cash | -472.62%-2.2B | -128.96%-741.24M | -140.30%-1.04B | 70.67%2.81B | -65.87%591.26M | 38.34%2.56B | 669.88%2.59B | 14.45%1.65B | 222.82%1.73B | 161.65%1.85B |
| Begining period cash | 54.46%8.02B | 54.46%8.02B | 54.46%8.02B | 46.39%5.19B | 46.39%5.19B | 46.39%5.19B | 46.39%5.19B | 73.40%3.55B | 73.40%3.55B | 73.40%3.55B |
| Cash at the end | 0.86%5.79B | -6.14%7.27B | -10.44%6.97B | 54.46%8.02B | 8.63%5.74B | 43.36%7.75B | 100.66%7.78B | 46.39%5.19B | 98.77%5.28B | 92.07%5.4B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | PricewaterhouseCoopers | -- | -- | -- | PricewaterhouseCoopers | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.